Raised $120M+ USD in private and public fundingBuilt a multinational team focusing on tumor specific targeted protein degradersOperating in US and South Korea

- R&D Global Leadership Team (since 2016)- R&D Senior Leadership Team (since 2014)- Chairperson, Asia Pacific Research Committee, a decision making body for project decisions and funding (2013-2015)- Research Working Group (RWG) Core Team member (Since 2014)- Research Working Group Stage gate committee observer - Asia Pacific R&D Hub Leadership Team member (Since 2014)- Translational Medicine 4 Patients (TM4P) member (Since 2013)- Asia Pacific R&D Leadership team (Since 2012)- Sanofi Korea leadership team (KCC) member ( Since 2013 ) (Sangmu/Managing Director)- Discovered of innovative medicine in liver disease via a virtual biotech model- Transformed a country-based team into a therapeutic area based team- Built a team of therapeutic area heads, senior scientists and postdocs (~20 FTE) embedded in key innovation clusters in East Asia (Daejeon, Shanghai, Tokyo) - Oversaw collaborations with leading academic and biotech partners in the region including U of Tokyo, Institute Pasteur, Asan Medical Center, KAIST, SNU, Fudan Univ

Korea R&D representativeInitiated early discovery projects in HBV and HCC using various modalities (siRNA, mAb, small molecule), some of them in clinical trials or a main asset of a NewCo

Structure based drug design for small molecule drug discovery - peptidomimetics, allosteric inhibitors. Co-led a first-in-class discovery project with direct reporting to the CEO Applied and proposed machine learning based new screening tree, which was adopted in the project team.Awarded a medal for innovative healthcare fusion idea by the CTO of LG ElectronicsR&D Strategic Planning (Deputy General Manager)Delivered corporate presentations at BioEurope and BioEurope Spring on behalf of LG and lead 1:1 partnering meetings Task Force Leader | Introduced rNPV to the company and used monte carlo simulation to conduct sensitivity analysis of the value of the portfolio of 16 discovery and development projects